new contract risk weigh sentiment
driven under-perform sinc last quarter remov
contract revenu note oep cost save
initi mismodel street suggest consensu
nexsi penetr launch next gener
plasma apheresi system nexsi initi penetr
rapid estim compani place placement
opportun end vast major
implement dm nexlynk saw
lead indic nexsi convers see admittedli taken
longer anticip earn announc
north american custom migrat migrat nexlynk see
unclear whether impli grifol adopt
nexsi delay convers channel dilig suggest
combin price negoti readi grifol occupi
acquir integr plasma center network
vocal price valu dynam despit delay continu view
contract matter extens channel dilig
suggest enhanc yield market ml real
seen center system nexsi disrupt note
detail system
risk-adjust revenu estim shift contract given grifol
contract yet sign approach guidanc
may like guid without contract
convers dilig indic immin contract sign
although expect see grifol adopt earlier saw
contract ad increment plasma revenu point
plasma growth remind increment revenu deriv
price tailwind abl realiz nexsi see upgrad
reason outlin feel prudent risk-adjust estim
shift contract revenu said continu believ
contract factor shift financi impact
one year versu remov associ contribut complet
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
assum total convers process grifol begin
see convers stagger due inventori
avail price model conserv dispos price
point lower prior assumpt grifol account
favor price and/or exist nexlynk contract exhibit
detail nexsi plasma build
consensu number achiev even without contract investor
highli focus presenc larg custom contract
estim whether like given proxim guidanc
may lack certainti attribut recent share price declin
number select move lower share under-perform market point
prior earn realiz lack contract would clear
disappoint sentiment perspect proprietari analysi suggest
even absenc larg contract next year consensu ebit/ep
estim achiev given presenc new cost-sav program
see breakdown follow foregon revenu contract
ebit oep save ebit net ebit
impact factor model arriv adjust ebit
estim vs prior still consensu
conclud even without contract consensu estim
achiev beatabl exhibit analysi
npv valu cost program off-set lack contract ebit
earn program involv cost save
major expect drop commentari suggest save
start realiz futur save back-half load
reflect model assum cadenc
assum drop-through rate analysi impli
npv cost save off-set lack
ebit custom contract henc worst-cas scenario addit
contract see current out-year ebit/ep estim achiev revis
base case scenario assum contract sign case
oep program would repres addit upsid consensu see
underappreci dynam appropri reflect street model
fundament thesi intact remain overweight recent share pressur prior
earn understand sentiment perspect given
investor becom uncertain regard contract continu
expect near-term risk number move lower long-term thesi
chang remain confid nexsi drive enhanc yield plasma
center confirm dilig support above-market plasma growth
announc cost program clear us profit inflect
continu without contract oep program drive bp
margin see compani becom activ capit
deploy buyback potenti long-term explor
strateg option blood busi remain overweight share
haemonet price target updat valuat methodolog
base ebitda estim discount back one year reflect
financi impact contract repres five-turn premium
peer unchang see defens given above-p organ growth
materi greater oper leverag
exhibit plasma revenu build stand-alone new contract
note assum dispos cost nexsi dispos cost grifols/csl nexsi dispos cost
new contract
note assum dispos cost nexsi dispos cost grifols/csl nexsi dispos cost
sale
sale
sale
sale
sale
sale
price target reflect ebitda discount
back one year five-turn premium smid cap peer given
superior organ growth profil materi greater leverag
upsid nexsi price cost save drop balanc sheet
option drive ebit achiev per liter
increment plasma price nexsi greater cost save drop
balanc sheet option third parti financ capit deploy drive
materi upsid ebit
nexsi cost restructur program drive ebit
haemonet abl achiev favor increment plasma price
nexsi save help compani exceed lrp ebit object
nexsi unabl gain materi price benefit nexsi unabl creat
materi valu custom and/or unabl obtain
competit price plasma growth remain line market growth rate
minim cost save drop
stori tie long-
rang plan lrp doubl oper incom
quadrupl turnaround
primarili lever nexsi compani
valu creation materi yield
opportun appreci see
posit backdrop nexsi drive
valu per liter plasma
custom expect share
profit increment per
liter price indic nexsi alon
drive lrp object
drive materi inflect
nexsi drive increment valu
per liter plasma custom
haemonet expect particip
oper excel program
drive bp margin
capit deploy via buyback
announc larg custom nexsi
capit deploy via buyback
progress cost restructur program
risk achiev price
larg custom declin convert
save program fail materi
dollar million except per share data
good sold
dollar million except per share data
dollar million except per share data
equival
accum comprehens incom
dollar million except per share data
loss asset dispos
chang work capit
net provid oper activ
capit intang asset
sale properti invest
net use invest activ
chang equiti
net financ activ
net chang
equival bop
equival eop
